Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
564
-
Total 13F shares, excl. options
-
91.1M
-
Shares change
-
+334K
-
Total reported value, excl. options
-
$24.5B
-
Value change
-
+$161M
-
Put/Call ratio
-
1.43
-
Number of buys
-
320
-
Number of sells
-
-230
-
Price
-
$269.27
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q1 2020
653 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q1 2020.
DEXCOM INC - Common Stock (DXCM) has 564 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91.1M shares
of 392M outstanding shares and own 23.26% of the company stock.
Largest 10 shareholders include FMR LLC (8.78M shares), VANGUARD GROUP INC (8.74M shares), BlackRock Inc. (5.95M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.84M shares), BAILLIE GIFFORD & CO (4.83M shares), MORGAN STANLEY (4.05M shares), JPMORGAN CHASE & CO (3.47M shares), JENNISON ASSOCIATES LLC (2.69M shares), STATE STREET CORP (2.05M shares), and BROWN ADVISORY INC (1.93M shares).
This table shows the top 564 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.